2.50
Hdl Handle:
http://hdl.handle.net/10033/621117
Title:
Cost-effectiveness of human papillomavirus vaccination in Germany.
Authors:
Damm, Oliver; Horn, Johannes; Mikolajczyk, Rafael T ( 0000-0003-1271-7204 ) ; Kretzschmar, Mirjam E E; Kaufmann, Andreas M; Deleré, Yvonne; Ultsch, Bernhard; Wichmann, Ole; Krämer, Alexander; Greiner, Wolfgang
Abstract:
The aim of this study was to assess the cost-effectiveness of human papillomavirus (HPV) vaccination in addition to the current cervical cancer screening programme in Germany using a dynamic transmission model.
Affiliation:
Hemholtz-Zentrum für Infektionsforschung GmbH, Inhoffenstr. 7, 38124 Braunschweig, Germany.
Citation:
Cost-effectiveness of human papillomavirus vaccination in Germany. 2017, 15:18 Cost Eff Resour Alloc
Journal:
Cost effectiveness and resource allocation : C/E
Issue Date:
2017
URI:
http://hdl.handle.net/10033/621117
DOI:
10.1186/s12962-017-0080-9
PubMed ID:
28878573
Type:
Article
Language:
en
ISSN:
1478-7547
Appears in Collections:
Publications of the AG (ESME)

Full metadata record

DC FieldValue Language
dc.contributor.authorDamm, Oliveren
dc.contributor.authorHorn, Johannesen
dc.contributor.authorMikolajczyk, Rafael Ten
dc.contributor.authorKretzschmar, Mirjam E Een
dc.contributor.authorKaufmann, Andreas Men
dc.contributor.authorDeleré, Yvonneen
dc.contributor.authorUltsch, Bernharden
dc.contributor.authorWichmann, Oleen
dc.contributor.authorKrämer, Alexanderen
dc.contributor.authorGreiner, Wolfgangen
dc.date.accessioned2017-09-22T09:49:34Z-
dc.date.available2017-09-22T09:49:34Z-
dc.date.issued2017-
dc.identifier.citationCost-effectiveness of human papillomavirus vaccination in Germany. 2017, 15:18 Cost Eff Resour Allocen
dc.identifier.issn1478-7547-
dc.identifier.pmid28878573-
dc.identifier.doi10.1186/s12962-017-0080-9-
dc.identifier.urihttp://hdl.handle.net/10033/621117-
dc.description.abstractThe aim of this study was to assess the cost-effectiveness of human papillomavirus (HPV) vaccination in addition to the current cervical cancer screening programme in Germany using a dynamic transmission model.en
dc.language.isoenen
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/4.0/*
dc.titleCost-effectiveness of human papillomavirus vaccination in Germany.en
dc.typeArticleen
dc.contributor.departmentHemholtz-Zentrum für Infektionsforschung GmbH, Inhoffenstr. 7, 38124 Braunschweig, Germany.en
dc.identifier.journalCost effectiveness and resource allocation : C/Een

Related articles on PubMed

This item is licensed under a Creative Commons License
Creative Commons
All Items in HZI are protected by copyright, with all rights reserved, unless otherwise indicated.